Search results
N-Power Medicine partners with MSD to expand access to oncology clinical trials
Clinical Trials Arena· 10 hours agoUS-based clinical research company N-Power Medicine has partnered with Merck & Co (MSD) to increase...
Orion to hand over exclusive rights to MSD for prostate cancer therapy
Pharmaceutical Technology· 1 day agoMerck & Co (MSD) has announced that its ongoing agreement with Orion Corporation for the co...
Merck’s pneumococcal vaccine gets CDC panel backing
BioPharma Dive· 4 days agoAdvisers to the agency unanimously recommended use of Capvaxive in older adults and in certain younger ones, putting it in the same tier as Pfizer's...
Pharma M&A: The top high value deals in 2023
Pharmaceutical Technology· 7 days agoFrom Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma mergers and acquisitions...
With revised IPO pitch, Artiva touts ‘natural killer’ cell therapy for autoimmune disease
BioPharma Dive· 1 day agoLike many of its cell therapy peers, Artiva, which originally sought an IPO in 2021, has shifted its...
Capvaxive will enhance protection against pneumococcal disease in older adults
Clinical Trials Arena· 6 days agoIPD rates are highest in children ages younger than five years, immunocompromised individuals with...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 2 days agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...
[Exclusive] Vernacular dating app flutrr swipes right on Huma Qureshi as an investor
YourStory· 19 hours agoIndia is the fifth-largest market for dating apps in the world, according to smallcase. Modern...